Contact Person : Nilufer Donmez; Last Date for the submission of abstract : Not Available ; Description : JAK kinase inhibitors will probably be the first new class of oral anti-inflammatories on the market. But which JAK or combinations of JAK enzymes is going to prove the best to inhibit in terms of side effects?